by Michael M. Messer, MD, and Irina V. Haller, PhD, MS Dr. Messer is with Behavioral Health Department, Essentia Health, Duluth, MN, and Dr. Haller is with Essentia Institute of
by Charles D. Cash, JD, LLM Mr. Cash is Assistant Vice President of Risk Management at PRMS, Inc., Arlington, Virginia. Innov Clin Neurosci. 2017;14(1–2)60–62. This ongoing column is dedicated to
Innov Clin Neurosci. 2017;14(1–2):11–12. Dear Editor: Sexual dysfunction (SD) after traumatic brain injury (TBI) is an often neglected and underreported issue within the medical field.[1,2] A recent interesting work by
Innov Clin Neuro. 2017;14(1–2):12–13. Dear Editor: Hyperglycemia is more common in patients being treated with an antipsychotic than in the general population.[1] However, hypoglycemia is also a severe complication of
Innov Clin Neurosci. 2017;14(1–2)3–23. A MESSAGE FROM THE EDITOR Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
by Swapnajeet Sahoo, MD; Aseem Mehra, MD; and Sandeep Grover, MD All from the Department of Psychiatry at the Postgraduate Institute of Medical Education and Research in Chandigarh, India Innov
by Takahiko Nagamine, MD, PhD Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Yamaguchi, Japan. Innov Clin Neurosci. 2016;13(11–12):28–31. Funding: No funding was received for the preparation of this
by Sangsoo Lee, MD, MSc; Chang Jin Oh, MD; and Jeong Won Seong, MD Dr. Lee is with the Department of Psychiatry at Ahav Hospital, South Korea; Dr. Oh is
by Justin Pope, JD Mr. Pope is Associate Risk Manager at PRMS, Inc. in Arlington, Virginia. Innov Clin Neurosci. 2016;13(11–12)37–40. This ongoing column is dedicated to providing information to our
by Malathi Latha Perugula, MD, and Steven Lippmann, MD The authors are from the Department of Psychiatry and Behavioral Science, University of Louisville School of Medicine, Louisville, Kentucky. Innov Clin
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
Dear Colleagues: Welcome to the September-October 2016 issue of Innovations in Clinical Neuroscience (ICNS). As the official journal of the CNS Summit, the International Society for CNS Drug Development (ISCDD),
by Glen P. Flores, PhD; Brian Peace, BS; Tony C. Carnes, PhD; Susan L. Baumgartner, PharmD, MBA; D. Eric Buffkin, Jr., MBA; Neil R. Euliano, PhD; and Larry N. Smith,
by Anthony L. Vaccarino, PhD; Kenneth R. Evans, PhD; Amir H. Kalali, MD; Sidney H. Kennedy, MD, FRCPC; Nina Engelhardt, PhD; Benico N. Frey, MD, MSc, PhD; John H. Greist,
by Franco Di Cesare, MD; Jessica Mancuso, PhD; Brian Silver, MD; and Peter T. Loudon, PhD Dr. Di Cesare is with Leoben Research Limited in Glasgow, UK; Dr. Mancuso is
by J. Gibson Pennington, MD, and Jeffrey Guina, MD From Wright-Patterson Air Force Base and Wright State University Boonshoft School of Medicine Department of Psychiatry, Dayton, Ohio Innov Clin Neurosci.
by Jonathan R. Scarff, MD Dr. Scarff is a staff psychiatrist at the Veterans Affairs Outpatient Clinic in Spartanburg, South Carolina, USA Innov Clin Neurosci. 2016;13(9–10):49–52 Funding: The author has
by Ann McNary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Innov Clin Neurosci. 2016;13(9–10)53–55. This ongoing column is dedicated to providing information to our
The Right to Die in Chronic Disorders of Consciousness: Can We Avoid the Slippery Slope Argument?
by Rocco Salvatore Calabrò, MD, PhD; Antonino Naro, MD, PhD; Rosaria De Luca, MS, PhD; Margherita Russo, MD, PhD; Lory Caccamo, PhD; Alfredo Manuli, MS; Alessia Bramanti; and Placido Bramanti,
Read More